Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02788708
What this trial is testing

Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer

Who this might be right for
Fallopian Tube CarcinomaRecurrent Ovarian CancerPrimary Peritoneal Carcinoma+1 more
Floor Backes 26
Testing effectiveness (Phase 2)Study completedNCT03287674
What this trial is testing

TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

Who this might be right for
Metastatic Ovarian Cancer
Inge Marie Svane 7
Testing effectiveness (Phase 2)Study completedNCT03742713
What this trial is testing

Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer

Who this might be right for
CancerOvarian Cancer
Cristal Therapeutics 25
Large-scale testing (Phase 3)Looking for participantsNCT06791460
What this trial is testing

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Obstetrics & Gynecology Hospital of Fudan University 296
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406674
What this trial is testing

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

Who this might be right for
FIGO Stage III Ovarian CancerPeritoneal CancerFallopian Tube Carcinoma
The Netherlands Cancer Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT02364713
What this trial is testing

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinosarcomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+24 more
Mayo Clinic 17
Testing effectiveness (Phase 2)UnknownNCT05475184
What this trial is testing

Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor

Who this might be right for
Ovarian Cancer
Onconic Therapeutics Inc. 58
Early research (Phase 1)Study completedNCT02483104
What this trial is testing

Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
AbbVie 9
Not applicableLooking for participantsNCT06032975
What this trial is testing

PRO for Fighting FT in Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 240
Large-scale testing (Phase 3)Looking for participantsNCT07318558
What this trial is testing

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Who this might be right for
Ovarian NeoplasmsOvarian Cancer
Merck Sharp & Dohme LLC 900
Early research (Phase 1)Looking for participantsNCT06234423
What this trial is testing

CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerSolid Tumor
OnCusp Therapeutics, Inc. 263
Testing effectiveness (Phase 2)Study completedNCT01705158
What this trial is testing

Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 87
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Not applicableStudy completedNCT01247779
What this trial is testing

Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy

Who this might be right for
Cervical CancerUterus CancerOvarian Cancer
Centre Oscar Lambret 386
Early research (Phase 1)Active Not RecruitingNCT04044859
What this trial is testing

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Who this might be right for
Endometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more
USWM CT, LLC 120
Not applicableLooking for participantsNCT03877796
What this trial is testing

Clinical Pre-screening Protocol for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Allarity Therapeutics 60
Not applicableLooking for participantsNCT06775470
What this trial is testing

Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

Who this might be right for
Ovarian Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 300
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Not applicableLooking for participantsNCT05251883
What this trial is testing

Analyze Data on Metastatic Ovarian Cancer Using Multi-omics

Who this might be right for
Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT00856791
What this trial is testing

Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Traws Pharma, Inc. 1
Next Page